Cost-effectiveness of olanzapine as a first-line treatment: a comment
- PMID: 16961554
- DOI: 10.1111/j.1524-4733.2006.00125.x
Cost-effectiveness of olanzapine as a first-line treatment: a comment
Comment on
-
Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.Value Health. 2006 Mar-Apr;9(2):77-89. doi: 10.1111/j.1524-4733.2006.00083.x. Value Health. 2006. PMID: 16626411 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

